In 2009, over 650,000 vascular closure devices (VCDs) were sold in the U.S. for use in peripheral vascular procedures, which accounted for approximately 20% of vascular closure devices used in all applications.
Vascular closure devices, which include both invasive and non-invasive products, are rapidly being adopted by the medical community. The market for VCDs is expected to exhibit strong growth through to 2016, thus driving the total U.S. market for peripheral vascular devices.
With the general shortage of nursing labor, many hospitals are finding it cost-effective and time-efficient to employ VCDs. Non-invasive VCDs remove the need for manual pressure by a healthcare worker and therefore also lessens labor costs. In addition, the use of invasive VCDs further reduces the time necessary to perform vascular closure.
Read more on the rise in use of VCDs and how this is affecting the U.S. PV market in iData Research’s new article in Healthcare Digital: